{
  "actions": [
    {
      "acted_at": "2013-07-18", 
      "committees": [
        "SSJU"
      ], 
      "references": [], 
      "status": "REFERRED", 
      "text": "Read twice and referred to the Committee on the Judiciary.", 
      "type": "referral"
    }, 
    {
      "acted_at": "2013-09-25", 
      "committee": "Committee on United States Senate Caucus on International Narcotics Control", 
      "committees": [
        "SCNC"
      ], 
      "in_committee": null, 
      "references": [], 
      "text": "Committee on United States Senate Caucus on International Narcotics Control. Hearings held.", 
      "type": "hearings"
    }, 
    {
      "acted_at": "2014-05-14", 
      "committee": "Committee on United States Senate Caucus on International Narcotics Control", 
      "committees": [
        "SCNC"
      ], 
      "in_committee": null, 
      "references": [], 
      "text": "Committee on United States Senate Caucus on International Narcotics Control. Hearings held.", 
      "type": "hearings"
    }
  ], 
  "amendments": [], 
  "bill_id": "s1322-113", 
  "bill_type": "s", 
  "by_request": false, 
  "committees": [
    {
      "activity": [
        "referral"
      ], 
      "committee": "Senate Judiciary", 
      "committee_id": "SSJU"
    }, 
    {
      "activity": [
        "hearings"
      ], 
      "committee": "Senate Caucus on International Narcotics Control", 
      "committee_id": "SCNC"
    }
  ], 
  "congress": "113", 
  "cosponsors": [
    {
      "district": null, 
      "name": "Begich, Mark", 
      "sponsored_at": "2014-02-27", 
      "state": "AK", 
      "thomas_id": "01898", 
      "title": "Sen", 
      "withdrawn_at": null
    }, 
    {
      "district": null, 
      "name": "Feinstein, Dianne", 
      "sponsored_at": "2013-07-18", 
      "state": "CA", 
      "thomas_id": "01332", 
      "title": "Sen", 
      "withdrawn_at": null
    }, 
    {
      "district": null, 
      "name": "Graham, Lindsey", 
      "sponsored_at": "2013-07-18", 
      "state": "SC", 
      "thomas_id": "00452", 
      "title": "Sen", 
      "withdrawn_at": null
    }, 
    {
      "district": null, 
      "name": "Schumer, Charles E.", 
      "sponsored_at": "2013-09-12", 
      "state": "NY", 
      "thomas_id": "01036", 
      "title": "Sen", 
      "withdrawn_at": null
    }, 
    {
      "district": null, 
      "name": "Whitehouse, Sheldon", 
      "sponsored_at": "2013-12-19", 
      "state": "RI", 
      "thomas_id": "01823", 
      "title": "Sen", 
      "withdrawn_at": null
    }
  ], 
  "enacted_as": null, 
  "history": {
    "active": true, 
    "active_at": "2013-09-25", 
    "awaiting_signature": false, 
    "enacted": false, 
    "vetoed": false
  }, 
  "introduced_at": "2013-07-18", 
  "number": "1322", 
  "official_title": "A bill to amend the Controlled Substances Act relating to controlled substance analogues.", 
  "popular_title": null, 
  "related_bills": [
    {
      "bill_id": "hr4975-113", 
      "reason": "related", 
      "type": "bill"
    }
  ], 
  "short_title": "SALTS Act", 
  "sponsor": {
    "district": null, 
    "name": "Klobuchar, Amy", 
    "state": "MN", 
    "thomas_id": "01826", 
    "title": "Sen", 
    "type": "person"
  }, 
  "status": "REFERRED", 
  "status_at": "2013-07-18", 
  "subjects": [
    "Crime and law enforcement", 
    "Drug trafficking and controlled substances", 
    "Drug, alcohol, tobacco use", 
    "Marketing and advertising"
  ], 
  "subjects_top_term": "Crime and law enforcement", 
  "summary": {
    "as": "Introduced", 
    "date": "2013-07-18", 
    "text": "Synthetic Abuse and Labeling of Toxic Substances Act of 2013 or the SALTS Act - Amends the Controlled Substances Act to provide that, in determining whether a controlled substance analogue was intended for human consumption, the following factors may be considered: (1) the marketing, advertising, and labeling of the substance; (2) the known efficacy or usefulness of the substance for the marketed, advertised, or labeled purpose; (3) the difference between the price at which the substance is sold and the price at which the substance it is purported to be or advertised as is normally sold; (4) the diversion of the substance from legitimate channels and the clandestine importation, manufacture, or distribution of the substance; and (5) whether the defendant knew or should have known that the substance was intended to be consumed by injection, inhalation, ingestion, or any other immediate means.\n\nDeclares that evidence that a substance was not marketed, advertised, or labeled for human consumption shall not by itself be sufficient to establish that the substance was not intended for human consumption."
  }, 
  "titles": [
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "SALTS Act", 
      "type": "short"
    }, 
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "Synthetic Abuse and Labeling of Toxic Substances Act of 2013", 
      "type": "short"
    }, 
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "A bill to amend the Controlled Substances Act relating to controlled substance analogues.", 
      "type": "official"
    }
  ], 
  "updated_at": "2015-09-01T10:21:54-04:00", 
  "url": "http://thomas.loc.gov/cgi-bin/bdquery/z?d113:SN1322:@@@L&summ2=m&"
}